Annual Total Long Term Liabilities
$208.08 M
+$2.84 M+1.38%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual total long term liabilities is $208.08 million, with the most recent change of +$2.84 million (+1.38%) on December 31, 2023.
- During the last 3 years, INBX annual total long term liabilities has risen by +$171.21 million (+464.39%).
- INBX annual total long term liabilities is now at all-time high.
Performance
INBX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly total long term liabilities is $0.00, unchanged on September 30, 2024.
- Over the past year, INBX quarterly long term liabilities has stayed the same.
- INBX quarterly long term liabilities is now -100.00% below its all-time high of $207.37 million, reached on September 30, 2023.
Performance
INBX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
INBX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.4% | 0.0% |
| 3 y3 years | +464.4% | -100.0% |
| 5 y5 years | +304.5% | -100.0% |
INBX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +175.2% | -100.0% | at low |
| 5 y | 5-year | at high | +464.4% | -100.0% | at low |
| alltime | all time | at high | +576.8% | -100.0% | at low |
Inhibrx Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(-100.0%) |
| Mar 2024 | - | $561.00 K(-49.5%) |
| Dec 2023 | $208.08 M(+1.4%) | $1.11 M(-99.5%) |
| Sep 2023 | - | $207.37 M(+0.3%) |
| Jun 2023 | - | $206.65 M(+0.3%) |
| Mar 2023 | - | $205.94 M(+0.3%) |
| Dec 2022 | $205.24 M(+171.4%) | $205.24 M(+17.6%) |
| Sep 2022 | - | $174.48 M(+0.3%) |
| Jun 2022 | - | $173.93 M(+52.9%) |
| Mar 2022 | - | $113.73 M(+50.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $75.61 M(+105.1%) | $75.61 M(-0.3%) |
| Sep 2021 | - | $75.83 M(-0.1%) |
| Jun 2021 | - | $75.90 M(+110.5%) |
| Mar 2021 | - | $36.06 M(-2.2%) |
| Dec 2020 | $36.87 M(-62.9%) | $36.87 M(+115.8%) |
| Sep 2020 | - | $17.09 M(+58.7%) |
| Jun 2020 | - | $10.77 M(-89.2%) |
| Dec 2019 | $99.49 M(+93.4%) | $99.49 M(+6.8%) |
| Jun 2019 | - | $93.16 M(+38.9%) |
| Mar 2019 | - | $67.05 M |
| Dec 2018 | $51.45 M(+67.3%) | - |
| Dec 2017 | $30.75 M | - |
FAQ
- What is Inhibrx Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual total long term liabilities year-on-year change?
- What is Inhibrx Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly long term liabilities year-on-year change?
What is Inhibrx Biosciences annual total long term liabilities?
The current annual total long term liabilities of INBX is $208.08 M
What is the all time high annual total long term liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual total long term liabilities is $208.08 M
What is Inhibrx Biosciences annual total long term liabilities year-on-year change?
Over the past year, INBX annual total long term liabilities has changed by +$2.84 M (+1.38%)
What is Inhibrx Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of INBX is $0.00
What is the all time high quarterly long term liabilities for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly total long term liabilities is $207.37 M
What is Inhibrx Biosciences quarterly long term liabilities year-on-year change?
Over the past year, INBX quarterly total long term liabilities has changed by $0.00 (0.00%)